|
|
|
|
|
|
|
|
|
|
Blogger's Note: open access after registration (free)
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial : The Lancet Oncology
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.